Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation

Artificial transcription factors (ATFs) and genomic nucleases based on a DNA binding platform consisting of multiple zinc finger domains are currently being developed for clinical applications. However, no genome-wide investigations into their binding specificity have been performed. We have created six-finger ATFs to target two different 18 nt regions of the human SOX2 promoter; each ATF is constructed such that it contains or lacks a super KRAB domain (SKD) that interacts with a complex containing repressive histone methyltransferases. ChIP-seq analysis of the effector-free ATFs in MCF7 breast cancer cells identified thousands of binding sites, mostly in promoter regions; the addition of an SKD domain increased the number of binding sites ∼5-fold, with a majority of the new sites located outside of promoters. De novo motif analyses suggest that the lack of binding specificity is due to subsets of the finger domains being used for genomic interactions. Although the ATFs display widespread binding, few genes showed expression differences; genes repressed by the ATF-SKD have stronger binding sites and are more enriched for a 12 nt motif. Interestingly, epigenetic analyses indicate that the transcriptional repression caused by the ATF-SKD is not due to changes in active histone modifications.

[1]  P. Lizardi,et al.  Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor , 2008, Molecular Cancer Therapeutics.

[2]  M. Rots,et al.  Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein‐2 promoter as a novel anti‐cancer treatment , 2007, Molecular carcinogenesis.

[3]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[4]  Ming-Ming Zhou,et al.  PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. , 2007, Molecular cell.

[5]  M. Rots,et al.  Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer , 2012, Nucleic acids research.

[6]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[7]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[8]  D. Segal,et al.  The generation of zinc finger proteins by modular assembly. , 2010, Methods in molecular biology.

[9]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[10]  E. Rebar,et al.  Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.

[11]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[12]  D J Segal,et al.  Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Bertram Ludäscher,et al.  Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data , 2009, Nucleic acids research.

[14]  Yuhua Wang,et al.  Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors* , 2012, The Journal of Biological Chemistry.

[15]  Farshid Guilak,et al.  Synergistic and tunable human gene activation by combinations of synthetic transcription factors , 2013, Nature Methods.

[16]  Gertraud Burger,et al.  Evolution of C2H2-zinc finger genes and subfamilies in mammals: Species-specific duplication and loss of clusters, genes and effector domains , 2008, BMC Evolutionary Biology.

[17]  Matthias Dobbelstein,et al.  Targeting tumour-supportive cellular machineries in anticancer drug development , 2014, Nature Reviews Drug Discovery.

[18]  R. Young,et al.  Transcriptional Regulation and Its Misregulation in Disease , 2013, Cell.

[19]  B. Cuevas,et al.  Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors , 2007, Oncogene.

[20]  Nathan C. Sheffield,et al.  The accessible chromatin landscape of the human genome , 2012, Nature.

[21]  J. Joung,et al.  Locus-specific editing of histone modifications at endogenous enhancers using programmable TALE-LSD1 fusions , 2013, Nature Biotechnology.

[22]  Pilar Blancafort,et al.  Epigenetic reprogramming of cancer cells via targeted DNA methylation , 2012, Epigenetics.

[23]  Raymond K. Auerbach,et al.  A User's Guide to the Encyclopedia of DNA Elements (ENCODE) , 2011, PLoS biology.

[24]  Sheng‐Chung Lee,et al.  Coactivator TIF1β Interacts with Transcription Factor C/EBPβ and Glucocorticoid Receptor To Induce α1-Acid Glycoprotein Gene Expression , 1998, Molecular and Cellular Biology.

[25]  P. Farnham,et al.  Using ChIP-seq technology to generate high-resolution profiles of histone modifications. , 2011, Methods in molecular biology.

[26]  J. W. Rooney,et al.  TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937. , 2001, Genes & development.

[27]  G. Maul,et al.  Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. , 2003, Genes & development.

[28]  P. Farnham,et al.  KAP1: AN ENIGMATIC MASTER REGULATOR OF THE GENOME , 2011 .

[29]  Pilar Blancafort,et al.  Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins. , 2003, Biochemistry.

[30]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[31]  P. Farnham,et al.  Can genome engineering be used to target cancer-associated enhancers? , 2014, Epigenomics.

[32]  Y L Chen,et al.  Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression. , 1998, Molecular and cellular biology.

[33]  H. Thiesen,et al.  Krüppel-associated boxes are potent transcriptional repression domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Farnham.  Insights from genomic profiling of transcription factors , 2009, Nature Reviews Genetics.

[35]  D. Segal,et al.  Genome engineering at the dawn of the golden age. , 2013, Annual review of genomics and human genetics.

[36]  Tamar Dvash,et al.  Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367 , 2014, Nucleic acids research.

[37]  D. C. Schultz,et al.  The KAP1 Corepressor Functions To Coordinate the Assembly of De Novo HP1-Demarcated Microenvironments of Heterochromatin Required for KRAB Zinc Finger Protein-Mediated Transcriptional Repression , 2006, Molecular and Cellular Biology.

[38]  Jin-Soo Kim,et al.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.

[39]  M. Marra,et al.  Characterization of the Contradictory Chromatin Signatures at the 3′ Exons of Zinc Finger Genes , 2011, PloS one.

[40]  Philipp Bucher,et al.  KRAB–Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading , 2010, PLoS genetics.

[41]  Henriette O'Geen,et al.  ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3′ Ends of ZNF Genes , 2010, PloS one.

[42]  G. Maul,et al.  SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. , 2002, Genes & development.

[43]  E. Laurenti,et al.  Modifications by Krab/kap1-mediated Histone Regulation of Episomal Gene Expression , 2009 .

[44]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[45]  Toni Cathomen,et al.  Unexpected failure rates for modular assembly of engineered zinc fingers , 2008, Nature Methods.

[46]  P. Farnham,et al.  Functional Analysis of KAP1 Genomic Recruitment , 2011, Molecular and Cellular Biology.

[47]  Xiaoyan Li,et al.  Progress of HDAC inhibitor panobinostat in the treatment of cancer. , 2014, Current drug targets.

[48]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[49]  D J Segal,et al.  Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Mazhar Adli,et al.  Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease , 2014, Nature Biotechnology.

[51]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[52]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[53]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[54]  Christopher M. Vockley,et al.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.

[55]  David A. Scott,et al.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.

[56]  D J Segal,et al.  Design of novel sequence-specific DNA-binding proteins. , 2000, Current opinion in chemical biology.

[57]  Peggy J. Farnham,et al.  KAP1 Protein: An Enigmatic Master Regulator of the Genome* , 2011, The Journal of Biological Chemistry.

[58]  Peter A. Jones,et al.  Targeting DNA methylation for epigenetic therapy. , 2010, Trends in pharmacological sciences.

[59]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[60]  D J Segal,et al.  Development of Zinc Finger Domains for Recognition of the 5′-ANN-3′ Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors* , 2001, The Journal of Biological Chemistry.

[61]  M. Rots,et al.  Step out of the groove: epigenetic gene control systems and engineered transcription factors. , 2006, Advances in genetics.

[62]  Guo-Liang Xu,et al.  Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter , 2013, Nucleic acids research.

[63]  P. Blancafort,et al.  Breaking through an epigenetic wall , 2013, Epigenetics.

[64]  Zhenqing Ye,et al.  Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3 , 2012, Genome Biology.

[65]  J. Drouin,et al.  TIF1β/KAP-1 Is a Coactivator of the Orphan Nuclear Receptor NGFI-B/Nur77* , 2009, Journal of Biological Chemistry.

[66]  R. Johnstone,et al.  New and emerging HDAC inhibitors for cancer treatment. , 2014, The Journal of clinical investigation.

[67]  P. Blancafort,et al.  Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs) , 2011, Epigenetics.

[68]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[69]  C. Pabo,et al.  Zif268 protein-DNA complex refined at 1.6 A: a model system for understanding zinc finger-DNA interactions. , 1996, Structure.